作者
Maria Riedmeier,Sonir Roberto Rauber Antonini,Sílvia Regina Brandalise,Tatiana El Jaick Bonifácio Costa,Camila Maia Martin Daiggi,Bonald C. Figueiredo,Ronald R. de Krijger,Karla Emília de Sá Rodrigues,Cheri Deal,Jaydira Del Rivero,Gernot Engstler,Martin Faßnacht,Gabriela C Fernandes Luiz Canali,Carlos A. Molina,E. Nazlı Gönç,M. Gültekin,Harm R. Haak,Tülay Güran,Emile J Hendriks Allaird,Jan Idkowiak,Michaela Kuhlen,David Malkin,Jagdish Prasad Meena,Christina Pamporaki,Emília M. Pinto,Soraya Puglisi,Raul C. Ribeiro,Lester D.�R. Thompson,Bilgehan Yalçın,Max M. van Noesel,Verena Wiegering
摘要
Mitotane is an important cornerstone in the treatment of pediatric adrenal cortical tumors (pACC), but experience with the drug in the pediatric age group is still limited and current practice is not guided by robust evidence. Therefore, we have compiled international consensus statements from pACC experts on mitotane indications, therapy, and management of adverse effects.